Tag: biosimilar entry timeline
Learn how the 12-year biologic exclusivity rule under the BPCIA delays biosimilar entry, impacting drug prices and patient access in the US compared to global markets.
Medications
Archives
Recent-posts
Peppermint Oil for IBS: What the Science Says and How to Use It Right
Dec, 6 2025
Crossover Trial Design: How Bioequivalence Studies Are Structured
Dec, 15 2025
Chinese Generic Production: Manufacturing and Quality Concerns in 2026
Jan, 10 2026
Meloset vs Other Melatonin Supplements: Pros, Cons & Best Alternatives
Oct, 24 2025
How and Where to Buy Furosemide Online: A Safe Guide for 2026
Jul, 23 2026